Assessing Omega-3 Therapy and Its Cardiovascular Benefits: What About Icosapent Ethyl? A Systematic Review and Meta-Analysis

<b>Background:</b> Lipid-lowering therapies are an option for stabilizing lipid levels. Icosapent ethyl (IPE) is a highly purified formulation of eicosapentaenoic acid, which can reduce lipid action, improve plaque stabilization, reduce platelet aggregation, lower TG, and prevent cardiovascular even...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Nathália Mendes Machado, Maria Vitória Barroso Oliveira, Karina Quesada, Jesselina Francisco dos Santos Haber, Ricardo José Tofano, Claudio José Rubira, Tereza Lais Menegucci Zutin, Rosa Direito, Eliana de Souza Bastos Mazuqueli Pereira, Camila Marcondes de Oliveira, Ricardo de Alvares Goulart, Vitor Engrácia Valenti, Kátia Portero Sloan, Lance Alan Sloan, Lucas Fornari Laurindo, Sandra Maria Barbalho
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	MDPI AG 2025-04-01
Sarja:	Pharmaceuticals
Aiheet:	Icosapent ethyl eicosapentaenoic acid EPA lipid-lowering therapies lipids cardiovascular diseases
Linkit:	https://www.mdpi.com/1424-8247/18/4/601
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!